Skip to main content
OpenTrials

Clinical trial condition

Tuberous Sclerosis

Explore clinical trials studying Tuberous Sclerosis. Study availability and eligibility vary by location and protocol.

33 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Tuberous Sclerosis trial results

Completed

Gait in Rare Diseases

NCT05161494

Conditions
Central Nervous System Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • University of Antwerp Antwerp, Belgium
View Trial Details
Completed

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

NCT03826628

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • All Children's Research Institute St. Petersburg, Florida, United States
  • Spectrum Health Grand Rapids, Michigan, United States
View all 17 locations
View Trial Details
Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

NCT04285346

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • Marinus Research Site Los Angeles, California, United States
  • Marinus Research Site Palo Alto, California, United States
  • Marinus Research Site Boston, Massachusetts, United States
  • Marinus Research Site Livingston, New Jersey, United States
View Trial Details
Completed

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00126672

Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Loma Linda University School of Medicine Loma Linda, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • New York University Medical Center New York, United States
View Trial Details

Related conditions